22:28:26 EDT Fri 11 Jul 2025
Enter Symbol
or Name
USA
CA



T:FRX - FENNEC PHARMACEUTICALS INC. J - https://fennecpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FRX - T  ·12.950.512.10-0.40-3.22.2252212.99  12.99  12.1012.99  5.6515:05:36Jun 0315 min RT 2¢
TSX - T·12.950.512.10-0.40-3.21.619812.99  12.99  12.1012.99  5.6515:05:3615 min
Alpha - A 12.500.0811    Jul 0315 min
CXD - D 12.38-0.12-1.00.44812.38  12.38  12.3809:31:4915 min
TriAct - M 12.500.0203    Sep 11/2015 min
Lynx - Y 12.37-0.13-1.00.11112.37  12.37  12.3709:31:4915 min
CS2 - S 12.500.0061    Jun 1715 min

Recent Trades - Last 10 of 22
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:53A11.93-0.57827 TD Sec79 CIBCE
15:28:03D11.98-0.52752 RBC7 TD SecE
15:27:00D11.96-0.5412 RBC7 TD SecE
15:05:36T12.10-0.4010019 Desjardins79 CIBCK
14:18:34T12.11-0.391001 Anonymous1 AnonymousK
14:18:34T12.11-0.391001 Anonymous1 AnonymousK
13:01:43D12.18-0.32947 TD Sec2 RBCE
11:50:48M12.19-0.3187 TD Sec2 RBCE
11:46:22T12.060.028279 CIBC2 RBC
11:44:22M12.33-0.171080 National Bank2 RBCE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-03 20:20C:FRX11.16News ReleaseFennec shareholders approve all matters at AGSM
2025-05-16 10:38C:FRX8.66SEDAR Interim MD & ASEDAR Interim MD & A
2025-05-16 10:33C:FRX8.66SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-13 06:03C:FRX8.66News ReleaseFennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
2025-05-09 04:02C:FRX9.04News ReleaseFennec to release Q1 results, host call May 13
2025-03-10 06:03C:FRX9.82News ReleaseFennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
2025-03-06 18:15C:FRX9.43News ReleaseFennec to release 2024 results March 10
2025-02-07 11:23C:FRX9.48News ReleaseFennec licensee begins selling Pedmarqsi in Germany
2024-12-20 14:02C:FRX8.46News ReleaseFennec's Pedmarqsi receives recommendation from NICE
2024-12-19 08:18C:FRX8.12News ReleaseFennec Pharmaceuticals repays $13M of Petrichor debt
2024-12-12 07:01C:FRX8.65News ReleaseFennec Pharmaceuticals to Participate in Upcoming Investor Conference
2024-11-13 06:27C:FRX5.92News ReleaseFennec Pharmaceuticals to Participate in Upcoming Investor Conference
2024-11-12 18:51C:FRX5.92SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-12 18:51C:FRX5.92SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-07 06:13C:FRX6.86News ReleaseFennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
2024-10-31 09:43C:FRX6.26News ReleaseFennec Pharmaceuticals to release Q3 results Nov. 7
2024-10-28 10:04C:FRX5.87News ReleaseFennec appoints Sayad as chief medical officer
2024-08-13 18:25C:FRX8.16SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-13 18:18C:FRX8.16SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-13 06:05C:FRX8.62News ReleaseFennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update